{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:54:06Z","timestamp":1791665646123,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ejphar.2011.06.049","type":"journal-article","created":{"date-parts":[[2011,7,10]],"date-time":"2011-07-10T12:36:22Z","timestamp":1310301382000},"page":"305-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation"],"prefix":"10.1016","volume":"668","author":[{"given":"Daniela","family":"Impellizzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Paterniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Melani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placido","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Pedata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.06.049_bb0005","first-page":"L1036","article-title":"Effect of adenosine A2A receptor activation in murine models of respiratory disorders","volume":"290","author":"Bonneau","year":"2006","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tins.2006.01.002","article-title":"Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?","volume":"29","author":"Bozzi","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0015","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1067\/mva.2002.123091","article-title":"Adenosine A2A analogue ATL-146e reduces systemic tumour necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia","volume":"35","author":"Cassada","year":"2002","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0020","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4049\/jimmunol.148.7.2201","article-title":"Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors","volume":"148","author":"Cronstein","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0706902","article-title":"Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice","volume":"149","author":"Cuzzocrea","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0030","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1164\/ajrccm.162.5.9912125","article-title":"Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan","volume":"162","author":"Cuzzocrea","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1189\/jlb.0605341","article-title":"The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation","volume":"79","author":"Cuzzocrea","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0040","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/labinvest.3780151","article-title":"The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat","volume":"80","author":"Cuzzocrea","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(24)01484-4","article-title":"Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia\/reperfusion injury","volume":"53","author":"Cuzzocrea","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0050","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.163.9.5094","article-title":"Role of IL-6 in the pleurisy and lung injury caused by carrageenan","volume":"163","author":"Cuzzocrea","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0055","doi-asserted-by":"crossref","first-page":"G285","DOI":"10.1152\/ajpgi.00348.2003","article-title":"Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction","volume":"286","author":"Day","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejphar.2004.11.041","article-title":"Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid","volume":"507","author":"Di Paola","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/SHK.0b013e3181c997dd","article-title":"Adenosine A2A receptor-selective stimulation reduces signalling pathways involved in the development of intestine ischemia and reperfusion injury","volume":"33","author":"Di Paola","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0070","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-18","article-title":"Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils","volume":"161","author":"Flamand","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.06.029","article-title":"Activation of adenosine receptors inhibits tumour necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity","volume":"497","author":"Fotheringham","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-2999(02)01305-5","article-title":"Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat","volume":"438","author":"Fozard","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.shk.0000190825.28783.a4","article-title":"Role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha in the development of bleomycin-induced lung injury","volume":"24","author":"Genovese","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0095","first-page":"73","article-title":"Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma","volume":"24","author":"Genovese","year":"2010","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2007.09.002","article-title":"The A3 adenosine receptor: an enigmatic player in cell biology","volume":"117","author":"Gessi","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjp.0703045","article-title":"A(2A) adenosine receptors in human peripheral blood cells","volume":"129","author":"Gessi","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0110","first-page":"319","article-title":"Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by l-DOPA in the rat striatum","volume":"60","author":"Golembiowska","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0115","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1182\/blood-2002-11-3624","article-title":"Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo","volume":"102","author":"Gomez","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00210-004-0970-1","article-title":"Binding of adenosine receptor ligands to brain of adenosine receptor knock-out mice: evidence that CGS 21680 binds to A1 receptors in hippocampus","volume":"370","author":"Halldner","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0125","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(05)80083-2","article-title":"Induction of nitric oxide synthase in asthma","volume":"342","author":"Hamid","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: an endogenous regulator of innate immunity","volume":"25","author":"Hasko","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0135","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14","author":"Hasko","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.0607359","article-title":"A2A receptors in inflammation and injury: lessons learned from transgenic animals","volume":"83","author":"Hasko","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0145","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.4049\/jimmunol.157.10.4634","article-title":"Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice","volume":"157","author":"Hasko","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0150","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/01.CCM.0000206467.19509.C6","article-title":"Adenosine A2A receptor activation reduces lung injury in trauma\/hemorrhagic shock","volume":"34","author":"Hasko","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0155","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1096\/fj.10-155192","article-title":"Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death","volume":"24","author":"Himer","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0160","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.167.11.6217","article-title":"Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors","volume":"167","author":"Hohlbaum","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0165","doi-asserted-by":"crossref","first-page":"13838","DOI":"10.1074\/jbc.M008589200","article-title":"Activation of protein kinase A and atypical protein kinase C by A(2A) adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1165\/ajrcmb\/2.2.193","article-title":"Characterization of the human peripheral lung adenosine receptor","volume":"2","author":"Joad","year":"1990","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0175","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/jappl.1995.78.3.990","article-title":"Adenosine A2 receptors reverse ischemia\u2013reperfusion lung injury independent of beta-receptors","volume":"78","author":"Khimenko","year":"1995","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002100000315","article-title":"Adenosine receptors and their ligands","volume":"362","author":"Klotz","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1359-6446(04)03044-2","article-title":"Targeting hypoxia\u2013A(2A) adenosine receptor-mediated mechanisms of tissue protection","volume":"9","author":"Lukashev","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clnu.2010.08.002","article-title":"Neuroprotective effects of almond skins in experimental spinal cord injury","volume":"30","author":"Mandalari","year":"2011","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1096\/fj.05-4804fje","article-title":"Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils","volume":"20","author":"McColl","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0200","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.ATV.21.5.791","article-title":"Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model","volume":"21","author":"McPherson","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11302-009-9174-y","article-title":"Adenosine A(2A) agonist and A(2B) antagonist mediate an inhibition of inflammation-induced contractile disturbance of a rat gastrointestinal preparation","volume":"6","author":"Michael","year":"2010","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/eji.200425524","article-title":"Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors","volume":"35","author":"Minguet","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0215","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0024-3205(96)00651-0","article-title":"Peroxynitrite: a two-faced metabolite of nitric oxide","volume":"60","author":"Muijsers","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0160-5402(85)90029-4","article-title":"Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium","volume":"14","author":"Mullane","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0225","first-page":"L1335","article-title":"Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice","volume":"292","author":"Nadeem","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0230","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0702866","article-title":"Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation","volume":"128","author":"Nantel","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0235","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3748\/wjg.v12.i4.568","article-title":"Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats","volume":"12","author":"Odashima","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0245","first-page":"F404","article-title":"Selective A2A adenosine receptor activation reduces ischemia\u2013reperfusion injury in rat kidney","volume":"277","author":"Okusa","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0250","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jss.2005.07.030","article-title":"Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas\/FasL","volume":"130","author":"Peng","year":"2006","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0255","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1046\/j.1365-2222.1998.00428.x","article-title":"Peroxynitrite in airway diseases","volume":"28","author":"Sadeghi-Hashjin","year":"1998","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2011.06.049_bb0260","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1476-5381.1996.tb15475.x","article-title":"Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation","volume":"118","author":"Salvemini","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cellsig.2007.10.005","article-title":"Regulating gene transcription in response to cyclic AMP elevation","volume":"20","author":"Sands","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0270","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/MCB.00207-06","article-title":"Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signalling 3 (SOCS-3) in vascular endothelial cells","volume":"26","author":"Sands","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0275","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-4159.2005.03395.x","article-title":"Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia","volume":"95","author":"Saura","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/sj.bjp.0703893","article-title":"Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists","volume":"132","author":"Sullivan","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0285","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(98)01193-6","article-title":"Role of poly(ADP-ribose) synthetase in inflammation and ischaemia\u2013reperfusion","volume":"19","author":"Szabo","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjp.2008.329","article-title":"Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions","volume":"155","author":"Trevethick","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0295","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/art.24794","article-title":"Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumour necrosis factor alpha but not methotrexate","volume":"60","author":"Varani","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2011.06.049_bb0300","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0006-2952(00)00414-7","article-title":"Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils","volume":"60","author":"Visser","year":"2000","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911007564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911007564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:01:40Z","timestamp":1785412900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911007564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":60,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0014299911007564"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.06.049","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}